ArticleMarine biotechnology (New York, N.Y.)2025
Functional Probiotic Intervention Reshapes Host Microbiota and Metabolite Profiles to Enhance Disease Resistance in Micropterus salmoides.
Article in Marine biotechnology (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protective Effects and Potential Mechanisms ofAnimals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In this study, Lactobacillus plantarum, Bacillus subtilis, and their 1:1 mixture were introduced into the aquaculture system of Micropterus salmoides for a duration of 42 days. Subsequently, a challenge test with Aeromonas hydrophila was performed. The objective was to evaluate the immunomodulatory and microbiota-regulating effects of these probiotics, with emphasis on intestinal microbial composition and serum metabolome shifts in treated versus control groups before and after infection. Results revealed a significant reduction in the relative abundance of A. hydrophila in the intestines of probiotic-treated fish (p < 0.05). Histological observations indicated improved intestinal integrity in treated groups. Metabolomic analysis identified significant alterations in serum compounds, particularly in carboxylic acids, organic oxygen compounds, glycerophospholipids, and fatty acyl derivatives (p < 0.05). Post-challenge, levels of pro-inflammatory metabolites were significantly lower in probiotic groups compared to controls. Microbial network analysis showed increased community modularity and stability in treated fish, with key shifts toward dominant genera such as Plesiomonas. These findings demonstrate that L. plantarum and B. subtilis effectively modulate host gut microbiota, reshape systemic metabolite profiles, and enhance immune resilience against bacterial infection. The observed microbiota-metabolome interactions underline the potential of these probiotics as functional feed additives for promoting fish health. The study provides mechanistic insights supporting the broader application of probiotic interventions in aquaculture and functional food development.
Indexed as
Identifiers
40938417What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.